510(k) K851635
K851635 is an FDA 510(k) premarket notification submitted by Diagnon Corp. for the device "DIAGNON HERPES IMMUNOPEROXIDASE TYPING TEST". The FDA issued a decision of Substantially Equivalent on October 10, 1985. The device falls under product code GQL (Antisera, Fluorescent, Herpesvirus Hominis 1,2), a Class II device regulated under 21 CFR 866.3305. Diagnon Corp. has at least 5 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 10, 1985
- Date Received
- April 18, 1985
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antisera, Fluorescent, Herpesvirus Hominis 1,2
- Device Class
- Class II
- Regulation Number
- 866.3305
- Review Panel
- MI
- Submission Type